ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Single-target Anti-VEGF Drugs Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-12I17994
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Single target Anti VEGF Drugs Market Research Report 2024
BUY CHAPTERS

Global Single-target Anti-VEGF Drugs Market Research Report 2024

Code: QYRE-Auto-12I17994
Report
August 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Novartis
Coherus BioSciences
Regeneron Pharmaceuticals
Samsung Bioepis
Biocon Biologics
Chengdu Kanghong Pharmaceutical

Single-target Anti-VEGF Drugs Market

Single-target anti-VEGF drugs are medications designed to specifically block the action of vascular endothelial growth factor(VEGF)in the eye.VEGF plays a crucial role in promoting the growth of abnormal blood vessels,which can lead to vision-threatening conditions such as wet age-related macular degeneration(AMD),diabetic retinopathy,and macular edema.
The global Single-target Anti-VEGF Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Single-target Anti-VEGF Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Single-target Anti-VEGF Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Single-target Anti-VEGF Drugs include Roche, Novartis, Coherus BioSciences, Regeneron Pharmaceuticals, Samsung Bioepis, Biocon Biologics, Chengdu Kanghong Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Single-target Anti-VEGF Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-target Anti-VEGF Drugs.
The Single-target Anti-VEGF Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Single-target Anti-VEGF Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-target Anti-VEGF Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Single-target Anti-VEGF Drugs Market Report

Report Metric Details
Report Name Single-target Anti-VEGF Drugs Market
Segment by Type
Segment by Application
  • Age-related Macular Degeneration
  • Diabetic Retinopathy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Novartis, Coherus BioSciences, Regeneron Pharmaceuticals, Samsung Bioepis, Biocon Biologics, Chengdu Kanghong Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Single-target Anti-VEGF Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Single-target Anti-VEGF Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Single-target Anti-VEGF Drugs Market report?

Ans: The main players in the Single-target Anti-VEGF Drugs Market are Roche, Novartis, Coherus BioSciences, Regeneron Pharmaceuticals, Samsung Bioepis, Biocon Biologics, Chengdu Kanghong Pharmaceutical

What are the Application segmentation covered in the Single-target Anti-VEGF Drugs Market report?

Ans: The Applications covered in the Single-target Anti-VEGF Drugs Market report are Age-related Macular Degeneration, Diabetic Retinopathy, Other

What are the Type segmentation covered in the Single-target Anti-VEGF Drugs Market report?

Ans: The Types covered in the Single-target Anti-VEGF Drugs Market report are Aflibercept, Conbercept, Ranibizumab, Brolucizumab, Faricimab, Other

Recommended Reports

Anti-VEGF Markets

Ophthalmic Drug Therapies

Cancer/Immunotherapy Drugs

1 Single-target Anti-VEGF Drugs Market Overview
1.1 Product Definition
1.2 Single-target Anti-VEGF Drugs by Type
1.2.1 Global Single-target Anti-VEGF Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Aflibercept
1.2.3 Conbercept
1.2.4 Ranibizumab
1.2.5 Brolucizumab
1.2.6 Faricimab
1.2.7 Other
1.3 Single-target Anti-VEGF Drugs by Application
1.3.1 Global Single-target Anti-VEGF Drugs Market Value by Application (2024-2030)
1.3.2 Age-related Macular Degeneration
1.3.3 Diabetic Retinopathy
1.3.4 Other
1.4 Global Single-target Anti-VEGF Drugs Market Size Estimates and Forecasts
1.4.1 Global Single-target Anti-VEGF Drugs Revenue 2019-2030
1.4.2 Global Single-target Anti-VEGF Drugs Sales 2019-2030
1.4.3 Global Single-target Anti-VEGF Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Single-target Anti-VEGF Drugs Market Competition by Manufacturers
2.1 Global Single-target Anti-VEGF Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Single-target Anti-VEGF Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Single-target Anti-VEGF Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Single-target Anti-VEGF Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Single-target Anti-VEGF Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Single-target Anti-VEGF Drugs, Product Type & Application
2.7 Global Key Manufacturers of Single-target Anti-VEGF Drugs, Date of Enter into This Industry
2.8 Global Single-target Anti-VEGF Drugs Market Competitive Situation and Trends
2.8.1 Global Single-target Anti-VEGF Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Single-target Anti-VEGF Drugs Players Market Share by Revenue
2.8.3 Global Single-target Anti-VEGF Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Single-target Anti-VEGF Drugs Market Scenario by Region
3.1 Global Single-target Anti-VEGF Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Single-target Anti-VEGF Drugs Sales by Region: 2019-2030
3.2.1 Global Single-target Anti-VEGF Drugs Sales by Region: 2019-2024
3.2.2 Global Single-target Anti-VEGF Drugs Sales by Region: 2025-2030
3.3 Global Single-target Anti-VEGF Drugs Revenue by Region: 2019-2030
3.3.1 Global Single-target Anti-VEGF Drugs Revenue by Region: 2019-2024
3.3.2 Global Single-target Anti-VEGF Drugs Revenue by Region: 2025-2030
3.4 North America Single-target Anti-VEGF Drugs Market Facts & Figures by Country
3.4.1 North America Single-target Anti-VEGF Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Single-target Anti-VEGF Drugs Sales by Country (2019-2030)
3.4.3 North America Single-target Anti-VEGF Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Single-target Anti-VEGF Drugs Market Facts & Figures by Country
3.5.1 Europe Single-target Anti-VEGF Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Single-target Anti-VEGF Drugs Sales by Country (2019-2030)
3.5.3 Europe Single-target Anti-VEGF Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Single-target Anti-VEGF Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Single-target Anti-VEGF Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Single-target Anti-VEGF Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Single-target Anti-VEGF Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Single-target Anti-VEGF Drugs Market Facts & Figures by Country
3.7.1 Latin America Single-target Anti-VEGF Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Single-target Anti-VEGF Drugs Sales by Country (2019-2030)
3.7.3 Latin America Single-target Anti-VEGF Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Single-target Anti-VEGF Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Single-target Anti-VEGF Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Single-target Anti-VEGF Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Single-target Anti-VEGF Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Single-target Anti-VEGF Drugs Sales by Type (2019-2030)
4.1.1 Global Single-target Anti-VEGF Drugs Sales by Type (2019-2024)
4.1.2 Global Single-target Anti-VEGF Drugs Sales by Type (2025-2030)
4.1.3 Global Single-target Anti-VEGF Drugs Sales Market Share by Type (2019-2030)
4.2 Global Single-target Anti-VEGF Drugs Revenue by Type (2019-2030)
4.2.1 Global Single-target Anti-VEGF Drugs Revenue by Type (2019-2024)
4.2.2 Global Single-target Anti-VEGF Drugs Revenue by Type (2025-2030)
4.2.3 Global Single-target Anti-VEGF Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Single-target Anti-VEGF Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Single-target Anti-VEGF Drugs Sales by Application (2019-2030)
5.1.1 Global Single-target Anti-VEGF Drugs Sales by Application (2019-2024)
5.1.2 Global Single-target Anti-VEGF Drugs Sales by Application (2025-2030)
5.1.3 Global Single-target Anti-VEGF Drugs Sales Market Share by Application (2019-2030)
5.2 Global Single-target Anti-VEGF Drugs Revenue by Application (2019-2030)
5.2.1 Global Single-target Anti-VEGF Drugs Revenue by Application (2019-2024)
5.2.2 Global Single-target Anti-VEGF Drugs Revenue by Application (2025-2030)
5.2.3 Global Single-target Anti-VEGF Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Single-target Anti-VEGF Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Single-target Anti-VEGF Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Single-target Anti-VEGF Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Single-target Anti-VEGF Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Single-target Anti-VEGF Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Coherus BioSciences
6.3.1 Coherus BioSciences Company Information
6.3.2 Coherus BioSciences Description and Business Overview
6.3.3 Coherus BioSciences Single-target Anti-VEGF Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Coherus BioSciences Single-target Anti-VEGF Drugs Product Portfolio
6.3.5 Coherus BioSciences Recent Developments/Updates
6.4 Regeneron Pharmaceuticals
6.4.1 Regeneron Pharmaceuticals Company Information
6.4.2 Regeneron Pharmaceuticals Description and Business Overview
6.4.3 Regeneron Pharmaceuticals Single-target Anti-VEGF Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Regeneron Pharmaceuticals Single-target Anti-VEGF Drugs Product Portfolio
6.4.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.5 Samsung Bioepis
6.5.1 Samsung Bioepis Company Information
6.5.2 Samsung Bioepis Description and Business Overview
6.5.3 Samsung Bioepis Single-target Anti-VEGF Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Samsung Bioepis Single-target Anti-VEGF Drugs Product Portfolio
6.5.5 Samsung Bioepis Recent Developments/Updates
6.6 Biocon Biologics
6.6.1 Biocon Biologics Company Information
6.6.2 Biocon Biologics Description and Business Overview
6.6.3 Biocon Biologics Single-target Anti-VEGF Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biocon Biologics Single-target Anti-VEGF Drugs Product Portfolio
6.6.5 Biocon Biologics Recent Developments/Updates
6.7 Chengdu Kanghong Pharmaceutical
6.7.1 Chengdu Kanghong Pharmaceutical Company Information
6.7.2 Chengdu Kanghong Pharmaceutical Description and Business Overview
6.7.3 Chengdu Kanghong Pharmaceutical Single-target Anti-VEGF Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Chengdu Kanghong Pharmaceutical Single-target Anti-VEGF Drugs Product Portfolio
6.7.5 Chengdu Kanghong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Single-target Anti-VEGF Drugs Industry Chain Analysis
7.2 Single-target Anti-VEGF Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Single-target Anti-VEGF Drugs Production Mode & Process
7.4 Single-target Anti-VEGF Drugs Sales and Marketing
7.4.1 Single-target Anti-VEGF Drugs Sales Channels
7.4.2 Single-target Anti-VEGF Drugs Distributors
7.5 Single-target Anti-VEGF Drugs Customers
8 Single-target Anti-VEGF Drugs Market Dynamics
8.1 Single-target Anti-VEGF Drugs Industry Trends
8.2 Single-target Anti-VEGF Drugs Market Drivers
8.3 Single-target Anti-VEGF Drugs Market Challenges
8.4 Single-target Anti-VEGF Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Novartis
Coherus BioSciences
Regeneron Pharmaceuticals
Samsung Bioepis
Biocon Biologics
Chengdu Kanghong Pharmaceutical
List of Tables
 Table 1. Global Single-target Anti-VEGF Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Single-target Anti-VEGF Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Single-target Anti-VEGF Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Single-target Anti-VEGF Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Single-target Anti-VEGF Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Single-target Anti-VEGF Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Single-target Anti-VEGF Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Single-target Anti-VEGF Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Single-target Anti-VEGF Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Single-target Anti-VEGF Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Single-target Anti-VEGF Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Single-target Anti-VEGF Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single-target Anti-VEGF Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Single-target Anti-VEGF Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Single-target Anti-VEGF Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global Single-target Anti-VEGF Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global Single-target Anti-VEGF Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global Single-target Anti-VEGF Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global Single-target Anti-VEGF Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Single-target Anti-VEGF Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global Single-target Anti-VEGF Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Single-target Anti-VEGF Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America Single-target Anti-VEGF Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Single-target Anti-VEGF Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America Single-target Anti-VEGF Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America Single-target Anti-VEGF Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Single-target Anti-VEGF Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Single-target Anti-VEGF Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Single-target Anti-VEGF Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Single-target Anti-VEGF Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Single-target Anti-VEGF Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Single-target Anti-VEGF Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Single-target Anti-VEGF Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Single-target Anti-VEGF Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Single-target Anti-VEGF Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Single-target Anti-VEGF Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Single-target Anti-VEGF Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Single-target Anti-VEGF Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Single-target Anti-VEGF Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Single-target Anti-VEGF Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Single-target Anti-VEGF Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Single-target Anti-VEGF Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Single-target Anti-VEGF Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Single-target Anti-VEGF Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Single-target Anti-VEGF Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Single-target Anti-VEGF Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Single-target Anti-VEGF Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Single-target Anti-VEGF Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global Single-target Anti-VEGF Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global Single-target Anti-VEGF Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global Single-target Anti-VEGF Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Single-target Anti-VEGF Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global Single-target Anti-VEGF Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Single-target Anti-VEGF Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global Single-target Anti-VEGF Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global Single-target Anti-VEGF Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global Single-target Anti-VEGF Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Single-target Anti-VEGF Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Single-target Anti-VEGF Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global Single-target Anti-VEGF Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Roche Single-target Anti-VEGF Drugs Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Novartis Single-target Anti-VEGF Drugs Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Coherus BioSciences Company Information
 Table 81. Coherus BioSciences Description and Business Overview
 Table 82. Coherus BioSciences Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Coherus BioSciences Single-target Anti-VEGF Drugs Product
 Table 84. Coherus BioSciences Recent Developments/Updates
 Table 85. Regeneron Pharmaceuticals Company Information
 Table 86. Regeneron Pharmaceuticals Description and Business Overview
 Table 87. Regeneron Pharmaceuticals Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Regeneron Pharmaceuticals Single-target Anti-VEGF Drugs Product
 Table 89. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 90. Samsung Bioepis Company Information
 Table 91. Samsung Bioepis Description and Business Overview
 Table 92. Samsung Bioepis Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Samsung Bioepis Single-target Anti-VEGF Drugs Product
 Table 94. Samsung Bioepis Recent Developments/Updates
 Table 95. Biocon Biologics Company Information
 Table 96. Biocon Biologics Description and Business Overview
 Table 97. Biocon Biologics Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Biocon Biologics Single-target Anti-VEGF Drugs Product
 Table 99. Biocon Biologics Recent Developments/Updates
 Table 100. Chengdu Kanghong Pharmaceutical Company Information
 Table 101. Chengdu Kanghong Pharmaceutical Description and Business Overview
 Table 102. Chengdu Kanghong Pharmaceutical Single-target Anti-VEGF Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Chengdu Kanghong Pharmaceutical Single-target Anti-VEGF Drugs Product
 Table 104. Chengdu Kanghong Pharmaceutical Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Single-target Anti-VEGF Drugs Distributors List
 Table 108. Single-target Anti-VEGF Drugs Customers List
 Table 109. Single-target Anti-VEGF Drugs Market Trends
 Table 110. Single-target Anti-VEGF Drugs Market Drivers
 Table 111. Single-target Anti-VEGF Drugs Market Challenges
 Table 112. Single-target Anti-VEGF Drugs Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Single-target Anti-VEGF Drugs
 Figure 2. Global Single-target Anti-VEGF Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Single-target Anti-VEGF Drugs Market Share by Type: 2023 & 2030
 Figure 4. Aflibercept Product Picture
 Figure 5. Conbercept Product Picture
 Figure 6. Ranibizumab Product Picture
 Figure 7. Brolucizumab Product Picture
 Figure 8. Faricimab Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Single-target Anti-VEGF Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 11. Global Single-target Anti-VEGF Drugs Market Share by Application: 2023 & 2030
 Figure 12. Age-related Macular Degeneration
 Figure 13. Diabetic Retinopathy
 Figure 14. Other
 Figure 15. Global Single-target Anti-VEGF Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Single-target Anti-VEGF Drugs Market Size (2019-2030) & (US$ Million)
 Figure 17. Global Single-target Anti-VEGF Drugs Sales (2019-2030) & (K Units)
 Figure 18. Global Single-target Anti-VEGF Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 19. Single-target Anti-VEGF Drugs Report Years Considered
 Figure 20. Single-target Anti-VEGF Drugs Sales Share by Manufacturers in 2023
 Figure 21. Global Single-target Anti-VEGF Drugs Revenue Share by Manufacturers in 2023
 Figure 22. Global 5 and 10 Largest Single-target Anti-VEGF Drugs Players: Market Share by Revenue in Single-target Anti-VEGF Drugs in 2023
 Figure 23. Single-target Anti-VEGF Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 24. Global Single-target Anti-VEGF Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 25. North America Single-target Anti-VEGF Drugs Sales Market Share by Country (2019-2030)
 Figure 26. North America Single-target Anti-VEGF Drugs Revenue Market Share by Country (2019-2030)
 Figure 27. United States Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Canada Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Europe Single-target Anti-VEGF Drugs Sales Market Share by Country (2019-2030)
 Figure 30. Europe Single-target Anti-VEGF Drugs Revenue Market Share by Country (2019-2030)
 Figure 31. Germany Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. France Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. U.K. Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Italy Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Russia Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Asia Pacific Single-target Anti-VEGF Drugs Sales Market Share by Region (2019-2030)
 Figure 37. Asia Pacific Single-target Anti-VEGF Drugs Revenue Market Share by Region (2019-2030)
 Figure 38. China Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Japan Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. South Korea Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. India Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Australia Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. China Taiwan Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Southeast Asia Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Latin America Single-target Anti-VEGF Drugs Sales Market Share by Country (2019-2030)
 Figure 46. Mexico Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Brazil Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Argentina Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Colombia Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Middle East and Africa Single-target Anti-VEGF Drugs Sales Market Share by Country (2019-2030)
 Figure 51. Middle East and Africa Single-target Anti-VEGF Drugs Revenue Market Share by Country (2019-2030)
 Figure 52. Turkey Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Saudi Arabia Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. UAE Single-target Anti-VEGF Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 55. Global Sales Market Share of Single-target Anti-VEGF Drugs by Type (2019-2030)
 Figure 56. Global Revenue Market Share of Single-target Anti-VEGF Drugs by Type (2019-2030)
 Figure 57. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 58. Global Sales Market Share of Single-target Anti-VEGF Drugs by Application (2019-2030)
 Figure 59. Global Revenue Market Share of Single-target Anti-VEGF Drugs by Application (2019-2030)
 Figure 60. Global Single-target Anti-VEGF Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 61. Single-target Anti-VEGF Drugs Value Chain
 Figure 62. Single-target Anti-VEGF Drugs Production Process
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Anti VEGF Ophthalmic Drugs Market Research Report 2024
Global Anti VEGT Drugs Market Research Report 2024
Global Anti VEGF Ophthalmic Drug Market Research Report 2024
Global Anti VEGF Drugs for Angiogenesis related Disease Market Research Report 2024
Global Monoclonal Antibody Anti VEGF Ophthalmic Drugs Market Research Report 2024
Global VEGF Inhibitors Market Research Report 2024
Global Anti VEGF Intravitreal Drugs Market Research Report 2024
Global VEGF A Inhibitor Market Research Report 2024
Global Anti VEGF Therapeutic Market Research Report 2025
Global Intravitreal Injection of Anti VEGF Drugs Market Research Report 2024
Global Fusion Protein Anti VEGF Ophthalmic Drugs Market Research Report 2024
Global Anti Vascular Endothelial Growth Factor Therapeutic Market Research Report 2025
Global Anti VEGF Therapy for Cancer Market Research Report 2024
Global VEGF Inhibitors for Cancer Market Research Report 2024
Global Anti VEGF Drugs for the Treatment of Wet AMD Market Research Report 2024
Global VEGFR 2 Inhibitor Market Research Report 2024
VEGF Inhibitor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal Antibody VEGF Inhibitors Market Research Report 2024
Anti vascular Endothelial Growth Factor Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti angiogenic Ophthalmic Agent Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions